• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

NanoViricides

edit

NanoViricides, Inc. is a nano-biopharmaceutical company whose business goals are to discover, develop and commercialize therapeutics (nanoviricidesâ„¢) to advance the care of patients suffering from life-threatening viral infections.

Recent Milestones

edit

• 
  NanoViricides received $5M in Venture Round funding. (6/29/12)
  Posted 6/29/12 at 6:07pm via masshightech.com
• 
  NanoViricides received $5M in Venture Round funding. (2/9/12)
  Posted 2/9/12 at 6:19pm via masshightech.com
• 
  NanoViricides received $2.5M in Venture Round funding. (7/27/11)
  Posted 7/27/11 at 5:40pm via masshightech.com
• 
  NanoViricides — NanoViricides lands $5M from stock offering (4/20/11)
  Posted 4/20/11 at 8:08pm via masshightech.com
• 
  NanoViricides added Eugene Seymour as Chief Executive Officer.
  Posted 4/20/11 at 8:07pm
• 
  NanoViricides added Anil R. Diwan as Chairman and President.
  Posted 4/20/11 at 8:07pm

Videos

Screenshots

edit

Above: NanoViricides
Uploaded: 4/21/11

Sources

1. NanoViricides raises $2.5M for antiviral drug development (masshightech.com) [edit]
2. NanoViricides nabs $5M to take flu fighter to IND (masshightech.com) [edit]
3. NanoViricides raises $5M to test anti-flu compound (masshightech.com) [edit]
NanoViricides lands $5M from stock offering (masshightech.com) [edit]